pulseTV

VIDEO: New Cardiac Radiotracers in Development

Nuclear Imaging | November 06, 2019

Robert C. Hendel, M.D., explains some of the new cardiac radiotracers in the pipeline that were discussed in sessions at the American Society of Nuclear Cardiology (ASNC) 2019 meeting. Hendel is a professor of medicine and radiology and the Sidney W. And Marilyn S. Lassen Chair in Cardiovascular Medicine, Tulane University. He also serves as the chief of the section of cardiology and director of the Tulane University Heart and Vascular Institute. 

He outlined three new radiotracers that may impact cardiac imaging:

   • Flurpiridaz F-18 PET perfusion agent that offers high quality images and can be used with exercise stress;

   • MIBG imaging to help better assess heart failure classes and if patients may need an ICD;

   • New F-18 agents to image cardiac amyloidosis; and

   • Nuclear agents to enable annexin imaging, allowing direct vsualization of myocardial apoptotic cells.

 

Recent Video

Wearables | February 28, 2019

Robert Klempfner, M.D., director of the Cardiovascular Prevention Institute, Sheba Medical Center, Israel,  discusses his center's use of wearable devices to manage a remote cardiac rehabilitation program. He spoke on the topic at 2019 Healthcare Information Management and Systems Society at (HIMSS) conference.   

Sheba Medical Center in Israel has adopted an app that interfaces with various wearables and Bluetooth-enabled patient monitoring devices to create remote cardiac rehabilitation and heart failure programs. It now remotely monitors hundreds of patients and does not require them to come to the hospital for sessions, which has helped increase patient satisfaction and aided in increasing physical activity compliance. The app is able to transfer device data to an EMR so progress and tasks assigned to patients can be monitored without the need for them to come into the hospital for sessions. Klempfner recently wrote a paper on this topic

Watch the related VIDEO: The Future of Wearables in Healthcare 

Look through a photo gallery of other new technologies at HIMSS19. 

Find news and videos from HIMSS 2019.

 

Wearables | February 28, 2019

How wearable devices will play a role in healthcare was a big topic at the Healthcare Information Management and Systems Society (HIMSS) 2019 meeting. The biggest question is how to attached the data from consumer devices into a usable format for clinicians that interfaces with the electronic medical record (EMR). A good example of how wearables are being integrated in clinical care was demonstrated by the company Datos. It offers software that can integrate data from a wide variety of wearable devices from several makers into a mobile app, It can transfer the information to an EMR. The app also offers two way communication between the patient and the doctor’s office. It can prompt patients with a list of things they need to do each day to reach physician specified goals and displays analytics on a patient’s health data, including charts and graphs.

The system is used by Sheba Medical Center in Israel for a remote cardiac rehabilitation program. It now remotely monitors hundreds of patients and does not require them to come to the hospital for sessions, which has helped increase patient satisfaction and aided in increasing physical activity compliance. Watch the VIDEO: Use of Wearable Medical Devices for Cardiac Rehabilitation — an interview with Robert Klempfner, M.D., director of the Cardiovascular Prevention Institute, Sheba Medical Center.
 

Look through a photo gallery of other new technologies at HIMSS19. 

Find news and videos from HIMSS 2019.

EP Lab | February 27, 2019

This is a virtual heart with the same electrophysiology characteristics as the real patient being developed to help optimize cardiac resynchronization therapy (CRT) lead placement. CRT currently has a 30 percent nonresponder rate, which is mainly due to the placement of leads. This model allows virtual placement of the leads In various locations to test response prior to the implantation procedure. The green dot shows the location of the virtual lead. It was unveiled at the Healthcare Information Management and Systems Society (HIMSS) 2019 annual meeting in February by Siemens. This "digital twin" technology is in development and will be able to create virtual, digital organs from a patient’s ECG, MRI scan and other clinical data. Siemens said the technology also might have applications for testing virtual ablations strategies to save procedure time when the patient is in the EP lab

Read more about the digital twin technology.

Look through a photo gallery of other new technologies at HIMSS19. 

Find news and videos from HIMSS 2019.

 

Enterprise Imaging | February 27, 2019

Steve Holloway, principal analyst and company director for the healthcare market research firm Signify Research, explains the key trends he is seeing in enterprise imaging systems. He spoke to ITN at the 2019 Healthcare Information Management and Systems Society at (HIMSS) conference.  

Additional HIMSS 2019 coverage.

Look through a photo gallery of new technologies highlighted at HIMSS 2019.

Watch the RSNA 2018 VIDEO: Technology Report — Enterprise Imaging

Heart Failure | February 13, 2019

William O'Neill, M.D., highlights best practice protocols based on Impella Quality database and real-world evidence showing improved outcomes in cardiogenic shock. Learn more at ProtectedPCI.com/DAIC

 

Related Impella Video Content:

VIDEO: Complex PCI Involving Prior CABG and Comorbidities — Interview with Perwaiz Meraj, M.D.

VIDEO: The Door-to-Unloading (DTU) STEMI Safety and Feasibility Trial — Interview with Navin Kapur, M.D.

VIDEO: Cardiogenic Shock Case with Impella CP Support — Case study with Michael Amponsah, M.D.,

 

Angiography | February 08, 2019

This is an example of an arterial venous malformation (AVM) in the brain imaged on a Canon Alphenix Alpha angiography system. It shjows a contrast injection highlighting the vessels, which have been color coded to show the position of the veins and arteries involved in this vascular defect. 

Read more about advances in angiography imaging systems. 

Artificial Intelligence | January 28, 2019

DAIC Editor Dave Fornell takes a tour of some of the most interesting new artificial intelligence (AI) imaging technologies on the expo floor of 2018 Radiological Society of North America (RSNA) annual meeting. Several of the new AI apps aid in faster iidentification of stroke, help in interventional vascular guidance for live embolizations, and speed workflow in medical imaging and reporting systems.

Watch the related VIDEO: Editor's Choice of the Most Innovative New Imaging Technologies at RSNA 2018

 

Related AI Imaging Technology Content:

New Cardiac Imaging Technologies Unveiled at RSNA 2018

VIDEO: Overview of Artificial Intelligence and its Use in Cardiology — Interview with Anthony Chang, M.D.

VIDEO: How Hospitals Should Prepare for Artificial Intelligence Implementation — Interview with Paul Chang, M.D.

VIDEO: Managing a Multi-site Radiology Practice With AI-based Workflow — Interview with Andrew Deutsch, M.D.

VIDEO: Technology Report: Artificial Intelligence

VIDEO: RSNA Post-game Report on Artificial Intelligence — ITN editors Dave Fornell and Greg Freiherr discuss the AI trends they saw at RSNA 2018

VIDEO: RSNA President Vijay Rao Says Artificial Intelligence is Hottest Tech Advancement in Radiology 

How Artificial Intelligence Will Change Medical Imaging

 

How to Market Healthcare Artificial Intelligence Software

Increasing Presence of AI at RSNA Reflects Emphasis on Efficiency

VIDEO: AI, Analytics and Informatics: The Future is Here — Interview with RSNA 2017 keynote speaker Michael Recht, M.D.

VIDEO: A Walk Through the RSNA 2018 Machine Learning Showcase

Selecting an AI Marketplace for Radiology: Key Considerations for Healthcare Providers

 

Increasing Presence of AI at RSNA Reflects Emphasis on Efficiency

Technology Report: Artificial Intelligence at RSNA 2018

RSNA 2018 Key Takeaways from the Expo Floor

VIDEO: How iCad Uses AI to Speed Breast Tomosynthesis

VIDEO: How Imalogix Uses AI to Boost Performance

 

VIDEO: Collaboration as a Catalyst for AI Innovation

PODCAST: How to Make Artificial Intelligence a Success in Medicine

VIDEO: Example of AI-assisted Oncology Patient Record Dashboard

 

 

Cardiac Imaging | January 26, 2019

DAIC Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies displayed on the expo floor at the 2018 Radiological Society of North America (RSNA) meeting. The video includes new technologies for fetal ultrasound, CT, MRI, mobile DR X-ray, a new generation of fluoroscopy systems, MRI contrast mapping to better identify tumors, and a new technique to create moving X-ray images from standard digital radiography (DR) imaging.

Watch the related VIDEO: Editor’s Choice of the Most Innovative New Artificial Intelligence Technologies at RSNA 2018. This includes a tour of some of the recently FDA-cleared AI technologies for medical imaging at RSNA 2018. 

 

Related Content:

New Cardiac Imaging Technologies Unveiled at RSNA 2018

VIDEO: Overview of Artificial Intelligence and its Use in Cardiology — Interview with Anthony Chang, M.D.

VIDEO: How Hospitals Should Prepare for Artificial Intelligence Implementation — Interview with Paul Chang, M.D.

Echocardiography Trends at ASE 2019

7 Hot Topics in Cardiac CT Imaging

 

 

Heart Valve Technology | January 25, 2019

Joe Cleveland, M.D., professor of cardiothoracic surgery, at the University of Colorado Hospital, offers a cardiac surgeon's perspective as part of the heart team for reviewing patient cases for transcatheter mitral and aortic interventions. He spoke about evaluating patients for MitraClip, transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR) procedures. He helps determine if a patient will benefit more from a transcatheter or surgical procedure. Cleveland also explains the impact of these transcatheter procedures on surgical volumes.

Watch the VIDEO: Evolution of Transcatheter Mitral Valve Repair at the University of Colorado.
 

Additional videos and coverage of the University of Colorado Hospital

January 10, 2019

Mark Anderson, M.D., FACS, vice chair of cardiac surgery services and cardiothoracic surgeon at Hackensack University Medical Group, outlines a multi-disciplinary heart team approach in treament decision-making for patients in cardiogenic shock. Learn more at ProtectedPCI.com/DAIC.

Anderson discusses improving outcomes for patients in cardiogenic shock through the early use of mechanical circulatory support and the development of a shock protocol with the heart team. He outlines Hackensack University Medical Center’s multi-disciplinary, heart team approach in treatment decision-making for patients in cardiogenic shock. The team includes cardiac surgeons, interventional cardiologists, heart failure specialists and intensivists. 

 

 

Cath Lab Navigation Aids | January 08, 2019

Robert Quaife, M.D., director of advanced cardiac imaging, University of Colorado Hospital, explains why advanced imaging techniques are required to tackle complex transcatheter procedures and structural heart interventions. The University of Colorado Hospital helped develop the Philips EchoNavigator live image fusion technology, and this video offers an overview of how it came to be and where the technology is going.

Watch the related VIDEO: Evolution of Transcatheter Mitral Valve Repair at the University of Colorado, which shows examples of the navigation technology is use during a MitraClip procedure. 

VIDEO: Overview of University of Colorado Structural Heart Program — Interview with John Carroll, M.D., Robert Quaife, M.D., and James Chen, Ph.D.

Highlighting Innovation at the University of Colorado Hospital Cardiology Program

Additional videos and coverage of the University of Colorado Hospital

 

 

Structural Heart Occluders | January 07, 2019

Karen Orjuela, M.D., assistant professor of neurology at the University of Colorado Stroke and Brain Aneurysm Center, explains the heart-brain team approach to screening cryptogenic stroke patients for transcatheter patent foramen ovale (PFO) closure. 

Additional videos and coverage of the University of Colorado Hospital

 

Related PFO Closure Content:

VIDEO: How Transcatheter PFO Closure Can Reduce Cryptogenic Stroke — Interview with 
John Rhodes, M.D., on the REDUCE PFO Trial

PFO Closure Shows Positive Results from REDUCE Clinical Study

VIDEO: PFO Closure Found Beneficial for Cryptogenic Stroke — Presentation of RESPECT Trial results by John Carroll,  M.D.

PFO Closure May Improve Outcomes Over Medical Therapy in Cryptogenic Stroke: Results of the RESPECT Trial
 

 

 

 

Structural Heart | January 07, 2019

John Carroll, M.D., FACC, FSCAI, director of interventional cardiology, and Robert Quaife, M.D., director of advanced cardiac imaging, explain the development of the transcatheter mitral valve repair program at the University of Colorado Hospital. The video include footage during a MitraClip procedure. 

VIDEO: Overview of University of Colorado Structural Heart Program — Interview with John Carroll, M.D., Robert Quaife, M.D., and James Chen, Ph.D.

Highlighting Innovation at the University of Colorado Hospital Cardiology Program

Additional videos and coverage of the University of Colorado Hospital

Chronic Total Occlusion (CTO) | January 03, 2019

Interview with John Messenger, M.D., FACC, FSCAI, director of the cardiac cath labs and director of the cardiovascular ICU/stepdown unit, and Kevin Rogers, M.D., director of vascular medicine at the University of Colorado Hospital. They explain the trend toward more complex procedures, including chronic total occlusions (CTOs) and complex high-risk indicated procedure (CHIP) patients. They explain how they minimize X-ray and contrast dose during these longer procedures, the tools they use to perform the procedures and offer advice for centers expanding into complex PCI.

Watch a VIDEO walk through of this cath lab at the University of Colorado Hospital.

VIDEO: Overview of University of Colorado Structural Heart Program — Interview with John Carroll, M.D., Robert Quaife, M.D., and James Chen, Ph.D.

Highlighting Innovation at the University of Colorado Hospital Cardiology Program

Find more content from the University of Colorado Hospital.

 

 

Cath Lab | January 03, 2019

This is a walk through inside one of the cardiac hybrid cath labs at the University of Colorado Hospital in Aurora, Colorado. It is centered around a bi-plane Philips AlluraClarity angiography system. In the lab are two echo systems. There is a Philips Epiq system for transesophageal echo (TEE) and to enable the EchoNavigator live echo/fluoro fusion imaging. There also is a Siemens ultrasound system to enable use of intra-cardiac echo (ICE).

For hemodynamic support there is both an Abiomed Impella console and a Teleflex intra-aortic balloon pump (IABP) console. The lab is equipped with an Acist automated contrast Injector. Also note the radial access boards. There are three rolling radiation shields in addition to a boom mounted Mavig shield. Anethesia is used in MitraClip procedures, which the lab is being prepped for in this video. 

Watch the related VIDEO: Cath Lab Walk Through at the University of Colorado Hospital

Find more articles and videos on the University of Colorado Hospital

 

EP Lab | January 03, 2019

This is a quick video tour of one of the dedicated electrophysiology (EP) labs at the University of Colorado Hospital. The room is built around a Siemens Artis Q.zen bi-plane angiography system. The system allows low radiation fluoro imaging, which reduced exposure to both patients and operators during long EP ablation procedures. 

Equipment in stock in this lab includes the Medtronic Artic Front cryoablation balloon.

Watch the VIDEO: Cryoballoon Ablation Best Practice Guidelines, an interview with Wilber Su, M.D.

Watch the related VIDEO: Cath Lab Walk Through at the University of Colorado Hospital
 

Find more articles and videos on the University of Colorado Hospital

Cath Lab | January 03, 2019

This is the newest cardiac cath lab at the University of Colorado Hospital in Aurora, Colorado. Construction was completed in June 2018. It is centered around a Philips Azurion Clarity IQ angiography system, which was chosen because its low X-ray dose imaging and guidance technologies that enable more complex, longer procedures. The room is use for the most involved complex percutaneous coronary interventions (PCI), including chronic total occlusions (CTOs) and complex high-risk indicated procedures (CHIP) patients. It is also used for transcatheter aortic valve replacement (TAVR), septal occluder procedures, transcatheter LAA closures and alcohol ablations.

The room is equipped for radial access procedures, which is used in a little more than 50 percent of cases at the hospital. It is also equipped with an Impella hemodynamic support system, wires and microcatheters for CTOs, and a SonoSite point of care ultrasound console for vascular access needle guidance.

See a 360 Degree View During a CTO Case in this room

Watch the VIDEO: The Evolution of Complex PCI at University of Colorado, which speaks with two of the operators who use this room.

 

Find more content from the University of Colorado Hospital.

 

Heart Failure | December 20, 2018

Andreas Brieke, M.D., director of mechanical circulatory support, heart failure physician and site principal investigator for the COAPT Trial at the University of Colorado Hospital, explains the impact of that study on the care of heart failure patients with functional mitral regurgitation. The trial used the MitraClip to treat patients with functional MR and showed it had a major impact on patient quality of life and heart function, offering a paradigm shift in care.  

Read the article "MitraClip Reduces Mortality for Heart Failure Patients With Secondary Mitral Regurgitation."

Watch the VIDEO: MitraClip to Treat Heart Failure — Results of the COAPT Trial, an interview with William Abraham, M.D.

Find more content from the University of Colorado Hospital.
 

 

 

Structural Heart | December 20, 2018

John Carroll, M.D., FACC, FSCAI, director of interventional cardiology at the Cardiac and Vascular Center at the University of Colorado Hospital, shares his insights from his own experience on what is needed to build a successful structural heart program.

Take virtual tours of the University of Colorado's hybrid cath lab and newest cath lab where most of their structural heart procedures are performed.

 

VIDEO: Overview of University of Colorado Structural Heart Program — Interview with John Carroll, M.D., Robert Quaife, M.D., and James Chen, Ph.D.

VIDEO: Evolution of Transcatheter Mitral Valve Repair at the University of Colorado

Highlighting Innovation at the University of Colorado Hospital Cardiology Program

Additional videos and coverage of the University of Colorado Hospital

 

Hemodynamic Support Devices | December 13, 2018

Michael Amponsah, M.D., FACC, an interventional cardiologist at Mohawk Valley Health System, shares a case of Impella CP for a non-ischemic cardiomyopathy patient who presented in cardiogenic shock. Learn more at ProtectedPCI.com/DAIC.

The patient, a 51-year-old male, was diagnosed with NYHA Class III non-ischemic systolic heart failure with an ejection fraction of 20 percent and an ICD. He presented to the emergency department with ICD shocks and his hemodynamics declined over a 12 hour period and blood work showed a 20 percent decline in kidney function. Amponsah placed a right heart cath and performed an echocardiogram showing LV dysfunction. The team decided to place an Impella CP in the cath lab to support the patient’s heart. This was effective in unloading the LV and organ perfusion. This also provided the team with time to transfer the patient to another facility.

 

Related Impella Video Content:

VIDEO: Complex PCI Involving Prior CABG and Comorbidities — Interview with Perwaiz Meraj, M.D.

VIDEO: Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device — Interview with William O'Neill, M.D.

VIDEO: The Door-to-Unloading (DTU) STEMI Safety and Feasibility Trial — Interview with Navin Kapur, M.D.

December 12, 2018

This is a walk around of the new Spectrum Dynamics Veriton SPECT-CT nuclear imaging system introduced at the 2018 Radiological Society of North America (RSNA) meeting.

This is a walk around of an innovative new SPECT-CT nuclear imaging system shown at the Radiological Society Of North America (RSNA) 2018 meeting this week. It's CT system with comes in 16, 64 or 128 slice configurations. It has 12 SPECT detector robotic arms that automatically move toward the patient and use a sensor to stop a few millimeters from the skin to optimize photon counts and SPECT image quality. It also uses more sensitive CZT digital detectors, which allows either faster scan times, or use of only half the radiotracer dose of analog detector scans.

Read the article “Nuclear Imaging Moves Toward Digital Detector Technology.” 

Read the article "Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition."

 

Cardiovascular Ultrasound | December 12, 2018

This is an example of the new Fetal HQ heart and vascular software from GE Healthcare for fetal ultrasound. The software, for the Voluson E10, helps evaluate the fetal heart shape, size and contractibility. A feature called Radiant Flow shows the blood flow in a 3-D view. It can also help show slow-flow blood, such as neuro-vascular circulation. This was shown for the first time at the 2018 Radiological Society of North America (RSNA) meeting.

 

Read more about this technology. 

 

Watch a VIDEO showing the fetal ventricular contractibility measures.

 

 

Advanced Visualization | December 12, 2018

This is an example of the FDA-cleared OpenSight augmented reality (AR) system for surgical planning from NovaRad at the Radiological Society Of North America (RSNA) 2018 meeting. It uses a HoloLens headset to register an overlay of the patient’s MR or CT scan in the patient. The operator can use hand movements to slice through and manipulate the images.

The vendor gained an FDA indication for AR to be used in surgical planning in 2018. NovaRad is working with the FDA for a second indication for use of the AR in the operating room during procedures.

This video is jerky, slightly misaligned and the hand movements did not always respond because itwas shot with an iPhone inside the visor. The image quality and hand movements are much better when actually wearing it on your head and aligned for the specific user.

Read more about this technology

Cybersecurity | December 12, 2018

Anton S. Becker, M.D., radiology resident at the University Hospital of Zurich, Switzerland, discusses the long-term risks of cyberattacks on medical imaging data at the 2018 Radiological Society of North America (RSNA) annual meeting.

Artificial Intelligence | December 12, 2018

This is an example of how artificial intelligence (AI) can help improve patient care by pulling together patient data from numerous sources n the elect if medical records that are specific to a patient’s diagnosis and treatment for a specific disease state. This is Siemens’ AI-Pathway Companion introduced at the Radiological Society Of North America (RSNA) 2018 meeting this week. In this examples. A prostate cancer patient has all their data on a single time line that can be accessed by single clicks on the points to open reports, images, procedures or labs.

At the end of the time line it integrates AI driven clinical decision support that recommends the next course of action based on clinical guidelines. The guidelines cited can also be opened for review by the clinician.

Cath Lab | November 15, 2018

Navin Kapur, M.D., discusses the results of the FDA STEMI Door-to-Unloading (DTU) safety and feasibility randomized controlled trial, presented as a late-breaking study at the 2018 American Heart Association meeting. Learn more at ProtectedPCI.com/DAIC.

 

Related Impella Video Content:

VIDEO: Complex PCI Involving Prior CABG and Comorbidities — Interview with Perwaiz Meraj, M.D.

VIDEO: Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device — Interview with William O'Neill, M.D.

VIDEO: Cardiogenic Shock Case with Impella CP Support — Case study with Michael Amponsah, M.D.,

 

 

Heart Failure | November 15, 2018

James Januzzi, M.D., Hutter Family Professor at Harvard Medical School and a cardiologist at Mass General Hospital,, Boston, spoke at the 2018 American Heart Association (AHA) meeting about blood biomarkers that can aid in assessing reverse remodeling in heart failure patients with reduced ejection fraction (HFrEF). 

Januzzi mentions the use of high sensitivity troponin in this video. Watch a VIDEO interview with Januzzi on his research with high sensitivity troponin.

 

 

EP Lab | November 15, 2018

Wilber Su, M.D., chief of cardiac electrophysiology, Banner University Medical Center, Phoenix, and clinical associate professor of medicine at the University of Arizona, explains the Heart Rhythm Society (HRS) best practices document on cryoballoon ablation. He led the development of that document. He spoke at the 2018 American Heart Association (AHA) meeting.

Read the HRS "Best practice guide for cryoballoon ablation in atrial fibrillation: The compilation experience of more than 3,000 procedures."

Read the related article "New Technologies to Improve Atrial Fibrillation Ablation."

 

 

Artificial Intelligence | November 14, 2018

James Januzzi, M.D., Hutter Family Professor at Harvard Medical School and a cardiologist at  Mass General Hospital, Boston, spoke at the 2018 American Heart Association (AHA) meeting about his use of artificial intelligence to data-mine patient records. He spoke at AHA on the use of an AI-driven model to predict acute kidney injury (AKI) in patients undergoing coronary angiography, and on the results from a catheter sampled blood archive in a cardiovascular disease study.

Read the related article "How Artificial Intelligence Will Change Medical Imaging."

 

 

 

Computed Tomography (CT) | November 14, 2018

Matthew Budoff, M.D., professor of medicine, David Geffen School of Medicine, UCLA, spoke at the 2018 American Heart Association (AHA) meeting on the new AHA guidelines for cholesterol, including the use of computed tomography (CT) calcium scoring scans to assess patient risk. Budoff has been involved in several of the coronary artery calcium (CAC) trials that supported the new recommendation.

 

 

Related CT Calcium Scorining Content:

VIDEO: New Cholesterol Guidelines Support CT Calcium Scoring for Risk Assessment — Interview with Matthew Budoff, M.D.

CT Calcium Scoring Becoming a Key Risk Factor Assessment

ACC and AHA Release Updated Cholesterol Guidelines for 2018

VIDEO: CT Calcium Scoring to Screen For Who Should Take Statins — Interview with Matthew Budoff, M.D.

VIDEO: The History of CT Calcium Scoring — Interview with Arthur Agatston, M.D.

 

 

 

Pharmaceuticals | November 13, 2018

Deepak L. Bhatt, M.D., executive director of the interventional cardiovascular program, Brigham and Women’s Hospital Heart & Vascular Center and Harvard Medical School, explains the results of the late-breaking REDUCE-IT Trial at the 2018 American Heart Association (AHA) meeting. This is a landmark study that showed icosapent ethyl (Vascepa) can significantly reduce major adverse cardiac and stroke events in patients with continued high triglyceride levels while on statin therapy.

Read the article on the REDUCE-IT Trial

Hypertension | November 07, 2018

Kim Allan Williams, Sr., M.D., chief of the Division of Cardiology and the James B. Herrick Professor at Rush University Medical Center, discusses the efforts being made by the Association of Black Cardiologists to reduce systemic hypertension in the African-American community. Williams is speaking on this topic at the American Heart Association 2018 meeting.

 

 

Cath Lab | November 07, 2018

In 2009, the GuideLiner Catheter revolutionized the concept of guide extension, creating new possibilities in interventional cardiology. Now in its third generation, the GuideLiner V3 Catheter continues to build on a history of innovation and performance — one that has been demonstrated with more than half a million catheters in cath labs around the world.

Teleflex also offers a family of Turnpike Catheters. These contain a robust multi-layer shaft that provides impressive flexibility, torque and tracking over a 0.014” guidewire in complex coronary and peripheral interventions. The unique five-layer composite shaft provides an ideal combination of flexibility and torque response to help navigate through complex anatomy while the outer polymer layer paired with a 60 cm distal hydrophilic coating facilitates smooth catheter delivery. This portfolio consists of the Turnpike Catheter (standard version), the Turnpike Spiral Catheter, the Turnpike Gold Catheter, and the Turnpike LP Catheter. Each catheter configuration contains a specific design element to address various clinical challenges in complex procedures

This year, Teleflex acquired two well-known PTCA balloon catheters. The Chocolate XD PTCA Balloon Catheter is a specialty angioplasty balloon, used in the pre-dilatation and treatment of coronary lesions. The balloon’s proprietary nitinol constraining structure creates “pillows” and “grooves” that are designed to provide controlled dilatation while minimizing vessel wall trauma.

The Glider PTCA Balloon Catheter is a semi-compliant balloon with a skived tip and low entry profile. The tip design, coupled with hydrophilic coating and an innovative, torqueable shaft, allows for precise tip orientation for use in crossing complex lesions and stent struts.

For more information: www.teleflex.com

Congenital Heart | November 01, 2018

Example of GE Healthcare’s FetalHQ software for the ultrasound imaging of fetal hearts. The new tool runs on GE Healthcare’s Voluson ultrasound systems and is the first tool to simultaneously examine the size, shape and function of the fetal heart echocardiography for congenital heart evaluations.

Read more about the technology in the article "Cardiac Ultrasound Software Streamlines Fetal Heart Exams."

 

 

Cath Lab | October 24, 2018

Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic support with the Impella 2.5 heart pump during high-risk PCI can reduce the risk of AKI even when those patients had pre-existing kidney disease and a low ejection fraction. For more information: http://bit.ly/2Pfaqxh

 

Related Impella Video Content:

VIDEO: Analysis of Outcomes for 15,259 U.S. Patients with AMICS Supported with the Impella Device — Interview with William O'Neill, M.D.

VIDEO: The Door-to-Unloading (DTU) STEMI Safety and Feasibility Trial — Interview with Navin Kapur, M.D.

VIDEO: Cardiogenic Shock Case with Impella CP Support — Case study with Michael Amponsah, M.D.

 

October 11, 2018

Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific, explains key trial data presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) conference. He also explained the company's recent purchase of numerous start-up companies to expand in areas of structural heart, venous interventions, electrophysiology and oncology. 

Hear Meredith's insights in the VIDEO: Future Research and Development Efforts in Cardiovascular Medicine

 

Overlay Init